Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Collaboration is key when it comes to supports for youth opioid use

Collaboration is key when it comes to supports for youth opioid use

Stories Aug 30, 2022 4 minutes

Researchers recommend improving youth’s access to harm reduction initiatives.

The drug toxicity crisis in British Columbia has claimed the lives of over 130 youth between January and May 2022. A new study led by Vancouver Coastal Health Research Institute researcher Dr. Danya Fast and published in the International Journal of Drug Policy highlights the importance of collaborating with youth who use drugs to find possible solutions to this crisis. 

The study calls for improvements to treatment options, such as opioid agonist therapy (OAT), for young people who use illicit drugs.

“Youth use opioids for many different reasons,” explains Fast, who has over 15 years of experience working with young people. “They are consumed for pleasure and as part of socialising, but also to treat physical, emotional, psychological and even economic pain, such as the pain of crushing, entrenched poverty.”

Dr. Danya Fast is a research scientist with the British Columbia Centre on Substance Use, as well as an assistant professor in the Department of Medicine and associate member in the Department of Anthropology at the University of British Columbia.

“When I first started working in this field, I would say that there was a lot more hopefulness among youth who use drugs,” she says. “Since the beginning of the COVID-19 pandemic in 2020, I have seen a lot more cynicism and despair from these youth about their opportunities for housing, employment and education.”

According to BC Mental Health and Substance Use Services, OAT “is a safe and effective medication-based treatment for people who are dependent on opioid drugs,” including heroin, oxycodone and fentanyl, and is often combined with other supports, such as counselling. 

OAT can help manage withdrawal symptoms and lower the risk of drug-related harms, such as fatal overdose and the transmission of hepatitis C or HIV, leading to improved treatment retention and outcomes. 

Despite being recognized as a critical tool for the treatment of opioid use disorder and harm reduction among youth, previously published research has suggested that Canadian youth who use drugs are significantly less likely to access OAT than adults, notes Fast.

Improving youth access and adherence to OAT

For her research, Fast interviewed 56 young people between the ages of 14 and 26 who reported using heroin or fentanyl two or more times per week and received some form of drug treatment therapy within the past six months. The research team used an interview guide developed in collaboration with a Youth Advisory Council of eight youth with lived experience of substance use and mental health concerns.

Interview topics included living conditions, drug use history, substance use treatment and service access across time, and also addressed how OAT impacted relationships with family, friends, health care professionals and romantic partners over time.

“A lot of the youth I have spoken with believed that OAT would enable the positive unfolding of their lives,” says Fast. “But, when that did not happen despite repeated attempts, it made it harder for them to imagine a different future via OAT. Many youth then concluded that OAT was irrelevant to their needs.”

“This work can be challenging and heartbreaking, but I always value my time with all the young people who have crossed my path. There has been a lot of laughter and fun, along with tears.”

The study team found that participants’ perceptions of OAT were often shaped by their peers, family members and romantic partners, some of whom raised concerns about such things as side effects and the potential efficacy and long-term health implications of the therapy. 

Daily witnessed dosing at a pharmacy during limited hours of operation was also identified by youth as a significant barrier to accessing and sticking with OAT. Many juggled poverty, various health challenges and unstable housing or homelessness, along with work and family commitments, which made the dispensing requirements unrealistic or burdensome, Fast explains. 

One participant noted the challenges of OAT: “I’ve got, you know, doctor’s appointments. I’m homeless so I’ve gotta figure out food in a day. I’ve got to figure out... shelter. I’ve got to figure out how to help my partner.”

While take-home OAT was available to some participants, Fast’s study found that accessing these ‘carries’ was often difficult and out of reach for many youth.

“I tried to call my pharmacy to get more carries, and they were like, ‘No’,” recalled a study participant, who eventually found a pharmacy willing to offer OAT due to temporary access measures introduced during the pandemic. “If it wasn’t for COVID, I never would have been able to get my meds and I would have had to leave the job site and miss out on, like, another $1,000 worth of work.”

Developing treatment interventions that better align with and address the needs of youth who use opioids could help improve treatment retention and outcomes, says Fast.

“We need to make sure that we are listening to and connecting with young people who use drugs, and then seeing how we can work with them and not against them.”

“The challenge lies in the fact that many youth tell me that they live in supportive housing, are impoverished and have no fun or pleasure in their lives, so drugs may offer them a way into pleasure and fun in that context,” says Fast.

Along with OAT and other harm reduction measures, Fast believes that treatment interventions should focus on the full spectrum of livelihood needs among young people. 

“This includes housing, employment, income support, opportunities for leisure and recreation, as well as cultural and spiritual practices,” she says. “Things that we all reach for in our lives.”

Researchers

Danya Fast

Related Articles

Long-term follow-ups improve health outcomes for people with substance use disorders

Public vote awards opioid detector philanthropic innovation prize

World-class substance use and addiction research centre joins VCH Research Institute

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

BC Centre on Substance Use

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy